Cargando…
EGFR Blockade Reverses Cisplatin Resistance in Human Epithelial Ovarian Cancer Cells
BACKGROUND: EOC is one of the most lethal gynecological malignancy worldwide. Although the majority of EOC patients achieve clinical remission after induction therapy, over 80% relapse and succumb to the chemoresistant disease. Previous investigations have demonstrated the association of EGFR with r...
Autores principales: | Poursheikhani, Arash, Yousefi, Hassan, Tavakoli-bazzaz, Javad, Ghaffari, Seyed H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pasteur Institute of Iran
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601546/ https://www.ncbi.nlm.nih.gov/pubmed/32660222 http://dx.doi.org/10.29252/ibj.24.6.365 |
Ejemplares similares
-
Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer
por: Huang, Linjuan, et al.
Publicado: (2023) -
Blockade of p75 Neurotrophin Receptor Reverses Irritability and Anxiety-Related Behaviors in a Rat Model of Status Epilepticus
por: Mehrabi, Soraya, et al.
Publicado: (2018) -
Early Parity Epigenetic Footprint of FOXA1 Gene Body in Normal Breast Tissue of Iranian Women
por: Zendehbad, Zahra, et al.
Publicado: (2019) -
Osteogenic Differentiation Effect of BMP-9 with Phenamil and Simvastatin on Intact Human Amniotic Epithelial Stem Cells
por: Ahmadi, Armin, et al.
Publicado: (2022) -
In silico Identification of Hypoxic Signature followed by reverse transcription-quantitative PCR Validation in Cancer Cell Lines
por: Shayan, Sara, et al.
Publicado: (2023)